Tag: Option Care Health

BANNOCKBURN, Ill. – Option Care Health saw double-digit growth in revenues as the company took advantage of its technology platform to respond to the disruption caused by the COVID-19 pandemic, said CEO John Rademacher on a recent earnings call.  Option Care Health reported net revenues of $804.7 million for the fourth quarter of 2020, an increase of 11.6% compared to the same quarter in 2019.  “Our ability to quickly pivot and utilize our technology...

BANNOCKBURN, Ill. – Option Care Health has agreed to sell 12 million shares of the company’s common stock at $20 per share in an underwritten public offering. The selling stockholder, an affiliate of Madison Dearborn Partners, also granted the underwriter a 30-day option to purchase up to 1.8 million additional shares of common stock. The offering is expected to close today, March 17. This sale of shares represents approximately 6.7% of the current shares outstanding. Option Care...

BANNOCKBURN, Ill. – Option Care Health reported net revenues of $804.7 million for the fourth quarter of 2020, an increase of 11.6% compared to the same quarter in 2019. Net revenues for the full year were about $3 billion, an increase of 31.3% compared to the full year 2019. Adjusted EBITDA for the quarter was $67.7 million, and $221.7 million for the full year, up 27.7% and 69.5%, respectively. “I am incredibly proud of the effort and execution by the Option Care Health team in...

BATON ROUGE, La., and BANNOCKBURN, Ill. – Option Care Health has partnered with Amedisys, a provider of home health, hospice and personal care, to provide COVID antibody infusion therapy in skilled nursing and assisted living facilities. In December, the National Home Infusion Association announced a pilot program with Operation Warp Speed and the Department of Health and Human Services to expand access to Bamlanivimab, which is being used to treat mild to moderate COVID-19 in adults and pediatrics...

BANNOCKBURN, Ill. - Option Care Health has been chosen to participate in a limited distribution network for VILTEPSO (viltolarsen) for patients with Duchenne Muscular Dystrophy who are amenable to exon 53 skipping therapy. Viltepso is among a growing number of chronic infusion therapies for neuromuscular disorders that Option Care Health is able to deliver to patients at home or in one of the company's more than 125 ambulatory infusion suites across the country. “Our demonstrated track record...

BANNOCKBURN, Ill. - While much of the current focus around the coronavirus pandemic focuses on respiratory complications, home infusion providers have been busy doing their part to help hospitals “clear the decks” and free up hospital beds for COVID-19 patients, says Harriet Booker, COO at Option Care Health.“We can work with them on a host of disease states to determine if the patient is suitable for home infusion,” she said, “and how quickly and safely we can get them...

BANNOCKBURN, Ill. - Option Care Health has expanded its use of Wolters Kluwer's Simplifi 797, its web-based compounding compliance solution. Option Care Health's expanded use of Wolters Kluwer's solutions will allow it to standardize training and promote nationwide adoption of best practices to ensure staff and patient safety, and maximize efficiency. “Safety and quality are at the forefront of everything we do,” said Don Filibeck, vice president of pharmacy. “Wolters Kluwer is...

BANNOCKBURN, Ill. - Option Care Health has been chosen by Highmark health plan as a preferred provider of factor drug products for the treatment and management of plan members with hemophilia, beginning in January 2020. Option Care Health has access to all hemophilia factor treatments, including those that are limited in distribution, as well as a Bleeding Disorders program with a care team that has Hemophilia Treatment Center training. “Highmark chose to partner with Option Care Health because...